Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oscar Rodríguez Faba

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Current Opinion in Urology|July 25, 2012
Predictive factors for recurrence progression and cancer specific survival in high-risk bladder cancerOscar Rodríguez Faba, Joan Palou
European Urology|April 12, 2018
Re: Value of an Immediate Intravesical Instillation of Mitomycin C in Patients with Non-muscle-invasive Bladder Cancer: A Prospective Multicentre Randomised Study in 2243 patientsOscar Rodríguez Faba, Alberto Breda, Joan Palou
World Journal of Urology|February 20, 2019
New predictive nomograms for non-muscle-invasive bladder cancer: it is all about the detailsWojciech Krajewski, Oscar Rodríguez Faba, Sławomir Poletajew, et al.
The Canadian Journal of Urology|October 27, 2010
The case for conservative management in the treatment of patients with non-muscle-invasive micropapillary bladder carcinoma without carcinoma in situJosep M Gaya, Joan Palou, Ferran Algaba, et al.
Archivos Espanoles De Urologia|May 11, 2018
[BCG and bladder cancer: Past, present and future.]Álvaro Sánchez González, Oscar Rodríguez Faba, Lucía Mosquera, et al.
Archivos Espanoles De Urologia|September 24, 2004
[Renal liposarcoma. Report of one case and bibliographic review]Oscar Rodríguez Faba, José Luís Martín Benito, Luís Parra Muntaner, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|September 30, 2016
Robot assisted retroperitoneal lymph-node dissection after adjuvant therapy: different indicationsVictor E Corona Montes, Antonio L Pastore, Louis Gausa, et al.
Urology|April 14, 2009
Recurrence at three months and high-grade recurrence as prognostic factor of progression in multivariate analysis of T1G2 bladder tumorsJuan Palou, Federico Rodríguez-Rubio, Félix Millán, et al.
European Urology|March 30, 2010
Neoadjuvant temsirolimus effectiveness in downstaging advanced non-clear cell renal cell carcinomaOscar Rodríguez Faba, Alberto Breda, Antonio Rosales, et al.
European Urology|November 22, 2011
Female gender and carcinoma in situ in the prostatic urethra are prognostic factors for recurrence, progression, and disease-specific mortality in T1G3 bladder cancer patients treated with bacillus Calmette-GuérinJoan Palou, Richard J Sylvester, Oscar Rodríguez Faba, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Current Opinion in Urology|July 25, 2012
Predictive factors for recurrence progression and cancer specific survival in high-risk bladder cancerOscar Rodríguez Faba, Joan Palou
European Urology|April 12, 2018
Re: Value of an Immediate Intravesical Instillation of Mitomycin C in Patients with Non-muscle-invasive Bladder Cancer: A Prospective Multicentre Randomised Study in 2243 patientsOscar Rodríguez Faba, Alberto Breda, Joan Palou
World Journal of Urology|February 20, 2019
New predictive nomograms for non-muscle-invasive bladder cancer: it is all about the detailsWojciech Krajewski, Oscar Rodríguez Faba, Sławomir Poletajew, et al.
The Canadian Journal of Urology|October 27, 2010
The case for conservative management in the treatment of patients with non-muscle-invasive micropapillary bladder carcinoma without carcinoma in situJosep M Gaya, Joan Palou, Ferran Algaba, et al.
Archivos Espanoles De Urologia|May 11, 2018
[BCG and bladder cancer: Past, present and future.]Álvaro Sánchez González, Oscar Rodríguez Faba, Lucía Mosquera, et al.
Archivos Espanoles De Urologia|September 24, 2004
[Renal liposarcoma. Report of one case and bibliographic review]Oscar Rodríguez Faba, José Luís Martín Benito, Luís Parra Muntaner, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|September 30, 2016
Robot assisted retroperitoneal lymph-node dissection after adjuvant therapy: different indicationsVictor E Corona Montes, Antonio L Pastore, Louis Gausa, et al.
Urology|April 14, 2009
Recurrence at three months and high-grade recurrence as prognostic factor of progression in multivariate analysis of T1G2 bladder tumorsJuan Palou, Federico Rodríguez-Rubio, Félix Millán, et al.
European Urology|March 30, 2010
Neoadjuvant temsirolimus effectiveness in downstaging advanced non-clear cell renal cell carcinomaOscar Rodríguez Faba, Alberto Breda, Antonio Rosales, et al.
European Urology|November 22, 2011
Female gender and carcinoma in situ in the prostatic urethra are prognostic factors for recurrence, progression, and disease-specific mortality in T1G3 bladder cancer patients treated with bacillus Calmette-GuérinJoan Palou, Richard J Sylvester, Oscar Rodríguez Faba, et al.
Pageof 5